Background. An association of chronic Chlamydia pneumoniae infection to coronary heart disease has been suggested recently. In a recent study, we demonstrated circulating immune complexes containing chlamydial genus-specific lipopolysaccharide in patients with coronary heart disease. The objective of the present study was to investigate whether C. pneumoniae species-specific immune complexes are present in chronic coronary heart disease. Methods and Results. The presence of Chlamydia-specific circulating immune complexes was studied in 46 patients with chronic coronary heart disease and in control subjects. Chlamydial lipopolysaccharidecontaining immune complexes were detected with the antigen-specific capture method, and they were present in 41% of patients and 15% of control subjects (p<0.61). The presence of C. pneumoniae antibodies in circulating immune complexes was studied by testing the specificity of antibodies derived from isolated and dissociated immune complexes by microimmunofluorescence testing and immunoblotting. The C. pneumoniae indexes based on the relative amount of immune complex-derived antibodies and free antibodies were significantly higher among patients compared with control subjects (median, 1/8 versus 1/16;p<0.001). Immune complex bound antibodies showed specificity for 98-kd and 42-kd proteins of C. pneumoniae.
Conclusions. The results suggest that the majority of the patients with chronic coronary heart disease have a chronic C. pneumoniae infection in which chlamydial components have an easy access to circulation to form immune complexes with preexisting antibodies. These findings give further evidence for the association of chronic C. pneumoniae infection with coronary heart disease. ( clearly higher in the CCHD group than in their control group. In this material, the levels of total cholesterol were higher in the control group than among CCHD patients, and in the multivariate analysis, the coefficient of total cholesterol was negative. The number of "eversmokers" and the levels of serum triglycerides were higher in the CCHD group. There was no association between CPI and smoking when only "current smokers" were coded as smokers. However, among ever-smokers, CPI levels were significantly higher compared with "never-smokers" (median, 1/8 versus 1/16; p<0.05). Multivariate analysis showed that the association of CPI to CCHD was independent of other coronary risk factors (Table 2) , and it was significant both among individuals with and without previous myocardial infarction (data not shown).
Immunoblotting Analysis of Dissociated ICs
After precipitation and dissociation of the circulating ICs of CCHD patients, the liberated IgG antibodies in immunoblotting exhibited a strong reactivity against C. pneumoniae protein antigens with molecular weights of 98 kd and 42 kd (Figure 2) . These proteins have been demonstrated earlier to be C. pneumoniae specific (see "Discussion"). The same specificity was seen in IC bound and free antibodies. The immunoblot pattern was similar in the CCHD patients and in the C. pneumoniae patients used as controls. patients could be due to the activation of a latent chlamydial infection by AMI.
In the present study, we were able to show that LPSICs are present also in about half of the patients with angiographically verified CCHD. LPSICs were detected by the IgM capture method in 63%, by the LPS capture method in 16%, and by both methods in 21% of positive cases. In our previous study, 70% of LPSICs in acute-phase AMI were demonstrable by the IgM capture method only, suggesting that the ICs were formed in LPS excess, whereas in the convalescent phase, 1 month after AMI, 65% of ICs were demonstrable only by LPS capture, now suggesting that ICs were formed in IgM antibody excess and that antibody response to LPS had happened after AMI.'0 The predominance of IgM capture findings in CCHD patients points to the LPS excess in the sera, just as in acute-phase AMI.
In this study, we further characterized the circulating ICs from CCHD patients and their healthy control subjects by isolating CICs and testing them for antibody to C. pneumoniae outer membrane protein antigens (OMP). The ratio of antibody titers free in serum and in dissociated complexes was significantly higher among patients compared with control subjects. In antibody prevalence surveys, C. pneumoniae antibodies have been very common, seen in about 50% in middle-aged adults all over the world.7 In the present study, we found only 16 (35%) seronegative CCHD cases (IgG titer <32). These patients did not have OMP-specific ICs in their serum either, whereas the patients who had low titer (32-64) often had high titers of complexed antibody and positive CPI as well. There was no indication of an acute C. pneumoniae infection in the present patient material (IgM was negative in all patients), and C. pneumoniae components still were present in the circulation, suggesting continuous shedding of chlamydial components, both proteins, and LPS into circulation. In the current study, C. trachomatis antibodies were seen only rarely, which is in good agreement with earlier studies of non-sexually transmitted disease patient materials. '8"19 Immunoblotting analysis of sera and dissociated ICs of CCHD patients revealed both free and complexed anti-. pneumoniae antibodies to 98-kd and 42-kd antigens. Campbell et a120 have demonstrated that the antibodies reactive with a 98-kd protein are C. pneumoniae specific because this protein was never recognized by sera from patients with C. trachomatis or C. psittaci infection. Recently, Puolakkainen et a12' studied immunoreactivity of sera from 49 South African adults with coronary arterial fatty streaks or fibrolipid plaques in immunoblotting, and 42-kd protein was frequently found to be immunoreactive in this material. Also, they reported that reactivity with the 98-kd and 42-kd proteins were species specific.
The levels of total cholesterol were higher in the control group than among CCHD patients. A similar result was obtained in our previous study, in which the same control group was used.22 Besides chance, the possibility that individuals with symptomatic CCHD had changed their diet may explain this paradoxical result. There was no association between smoking and CPI when only current smokers were coded as smokers. However, an association was found between ever-smoking and CPI. The association between smoking and C. pneumoniae antibody has been reported also in the Helsinki Heart Study'" and in a recent study by a Seattle group. 23 Hahn and Golubjatnikov24 recently reported a significant quantitative association between current smoking and C. pneumoniae serological titer. The reason for the association between smoking and C. pneumoniae antibody remains unclear. It could be speculated that because smoking has a harmful effect on the defense mechanisms on the respiratory tract, the lung tissue will become susceptible to chronic C. pneumoniae infection, which may lead to CHD.
There are several mechanisms by which chronic C. pneumoniae infection might contribute to the development of CHD. C. pneumoniae has been shown to multiply in alveolar macrophages25 and in endothelial cells26; chlamydial components in chronic lung infections thus might have an easy access to circulation to form ICs with preexisting antibodies. These ICs could contribute to the development of atherosclerosis by deposition on the vessel wall, creating local inflammatory and procoagulant changes.",2728 Binding of ICs to endothelial cells, phagocytic cells, platelets, or erythrocytes could initiate a process leading to the release of a variety of mediators, including cell proliferative factors.1 LPS itself is also known for its deleterious effects on the blood coagulation system and on vascular endothelium. 29-3' The CIC findings in the present study suggest that majority of CCHD patients have a chronic C. pneumoniae infection. The immunoblotting analysis as well as microimmunofluorescence tests confirmed that the antibody and IC findings were indeed specific for C. pneumoniae. The presence of C. pneumoniae proteinspecific ICs in the sera of CCHD patients gives further evidence for an association of a chronic C. pneumoniae infection with CHD.
